{"id":391579,"date":"2021-11-09T08:40:04","date_gmt":"2021-11-09T11:40:04","guid":{"rendered":"https:\/\/www.ip.gov.py\/ip\/?p=391579"},"modified":"2021-11-09T08:40:04","modified_gmt":"2021-11-09T11:40:04","slug":"salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad","status":"publish","type":"post","link":"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/","title":{"rendered":"Salud P\u00fablica aprueba uso de AstraZeneca en mayores de 18 a\u00f1os de edad"},"content":{"rendered":"<p style=\"text-align: justify;\"><em><strong>Asunci\u00f3n, Agencia IP.-<\/strong><\/em> El Ministerio de Salud P\u00fablica aprob\u00f3 la vacunaci\u00f3n con AstraZeneca a personas mayores de 18 a\u00f1os en adelante, tras la recomendaci\u00f3n del Comit\u00e9 Nacional Asesor de Inmunizaciones (Cotenai), que expuso resultados de evidencias cient\u00edficas que demuestran la seguridad de esta vacunas en este grupo etario.<!--more--><\/p>\n<p style=\"text-align: justify;\">Tras haberse comprobado la eficacia y seguridad en la aplicaci\u00f3n de vacunas a mayores de 18 a\u00f1os, teniendo en cuenta la instrucci\u00f3n del fabricante, sumado a la aprobaci\u00f3n de la Organizaci\u00f3n Mundial de la Salud (OMS) y otras agencias regulatorias internacionales como la Agencia Europea de Medicamentos, la cartera sanitaria baja el rango de edad a 18 a\u00f1os para la inmunizaci\u00f3n con la AstraZeneca.<\/p>\n<p style=\"text-align: justify;\">As\u00ed tambi\u00e9n, se ha evaluado que los beneficios de la vacuna son muy altas en la poblaci\u00f3n y la misma permite evitar el desarrollo grave de la enfermedad y\/o posibles fallecimientos al igual que las otras plataformas disponibles en el pa\u00eds.<\/p>\n<p style=\"text-align: justify;\">Cabe mencionar que, la Sociedad de Hematolog\u00eda ha referido que la asociaci\u00f3n de la aplicaci\u00f3n de vacunas a personas con antecedentes de trombosis y sus efectos colaterales no est\u00e1 sostenida. Esta relaci\u00f3n, solo se guarda en aquellas que desarrollaron trombocitopenia asociada al uso de heparina (anticoagulante), por este motivo, su uso est\u00e1 garantizado.<\/p>\n<p style=\"text-align: justify;\">Igualmente, desde la cartera sanitaria se insiste en la importancia de no relajarse y mantener las medidas sanitarias de protecci\u00f3n como el lavado de manos, uso de mascarilla, distanciamiento f\u00edsico y ventilaci\u00f3n de espacios cerrados, como herramientas fundamentales de lucha y mitigaci\u00f3n del impacto que pueda generar esta enfermedad.<\/p>\n<h4 style=\"text-align: justify;\"><strong>Enlaces cient\u00edficos que sustentan el uso de AstraZeneca en mayores de 18 a\u00f1os:<\/strong><\/h4>\n<p style=\"text-align: justify;\">1-\u00a0\u00a0\u00a0\u00a0\u00a0<a href=\"https:\/\/apps.who.int\/iris\/handle\/10665\/344913\" target=\"_blank\" rel=\"noopener\"> Recomendaciones provisionales sobre el uso de la vacuna ChAdOx1-S<\/a> [recombinante] contra la covid-19. Orientaciones provisionales Versi\u00f3n inicial: 10 de febrero de 2021 Primera actualizaci\u00f3n: 21 de abril de 2021 Actualizaci\u00f3n m\u00e1s reciente: 30 de julio de 2021<\/p>\n<p style=\"text-align: justify;\">2-\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"text-decoration: underline;\"><a href=\"https:\/\/www.ema.europa.eu\/en\/documents\/covid-19-vaccine-safety-update\/covid-19-vaccine-safety-update-vaxzevria-previously-covid-19-vaccine-astrazeneca-6-october-2021_en.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/www.ema.europa.eu\/en\/documents\/covid-19-vaccine-safety-update\/covid-19-vaccine-safety-update-vaxzevria-previously-covid-19-vaccine-astrazeneca-6-october-2021_en.pdf<\/a><\/span><\/p>\n<p style=\"text-align: justify;\">3-\u00a0\u00a0\u00a0\u00a0\u00a0 <a href=\"https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/covid19-industry\/drugs-vaccines-treatments\/vaccines\/astrazeneca.html\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\">https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/covid19-industry\/drugs-vaccines-treatments\/vaccines\/astrazeneca.html<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Asunci\u00f3n, Agencia IP.- El Ministerio de Salud P\u00fablica aprob\u00f3 la vacunaci\u00f3n con AstraZeneca a personas mayores de 18 a\u00f1os en adelante, tras la recomendaci\u00f3n del Comit\u00e9 Nacional Asesor de Inmunizaciones (Cotenai), que expuso resultados de evidencias cient\u00edficas que demuestran la seguridad de esta vacunas en este grupo etario.<\/p>\n","protected":false},"author":23,"featured_media":391584,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[2,4],"tags":[5161,162,9498,91],"class_list":{"0":"post-391579","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-destacado","8":"category-nacionales","9":"tag-astrazeneca","10":"tag-paraguay","11":"tag-plan-nacional-de-vacunacion-anticovid-19","12":"tag-salud-publica"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Salud P\u00fablica aprueba uso de AstraZeneca en mayores de 18 a\u00f1os de edad - .::Agencia IP::.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Salud P\u00fablica aprueba uso de AstraZeneca en mayores de 18 a\u00f1os de edad - .::Agencia IP::.\" \/>\n<meta property=\"og:description\" content=\"Asunci\u00f3n, Agencia IP.- El Ministerio de Salud P\u00fablica aprob\u00f3 la vacunaci\u00f3n con AstraZeneca a personas mayores de 18 a\u00f1os en adelante, tras la recomendaci\u00f3n del Comit\u00e9 Nacional Asesor de Inmunizaciones (Cotenai), que expuso resultados de evidencias cient\u00edficas que demuestran la seguridad de esta vacunas en este grupo etario.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/\" \/>\n<meta property=\"og:site_name\" content=\".::Agencia IP::.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPParaguay\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-09T11:40:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/11\/Vacunacion-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1127\" \/>\n\t<meta property=\"og:image:height\" content=\"733\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Noelia Ferreira\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:site\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Noelia Ferreira\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/11\\\/09\\\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/11\\\/09\\\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\\\/\"},\"author\":{\"name\":\"Noelia Ferreira\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/791af27a9219bdbf9064abb776bb41c2\"},\"headline\":\"Salud P\u00fablica aprueba uso de AstraZeneca en mayores de 18 a\u00f1os de edad\",\"datePublished\":\"2021-11-09T11:40:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/11\\\/09\\\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\\\/\"},\"wordCount\":374,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/11\\\/09\\\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Vacunacion-1.jpg\",\"keywords\":[\"AstraZeneca\",\"paraguay\",\"Plan Nacional de Vacunaci\u00f3n anticovid-19\",\"Salud P\u00fablica\"],\"articleSection\":[\"Destacado\",\"Nacionales\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/11\\\/09\\\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/11\\\/09\\\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\\\/\",\"name\":\"Salud P\u00fablica aprueba uso de AstraZeneca en mayores de 18 a\u00f1os de edad - .::Agencia IP::.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/11\\\/09\\\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/11\\\/09\\\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Vacunacion-1.jpg\",\"datePublished\":\"2021-11-09T11:40:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/11\\\/09\\\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/11\\\/09\\\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/11\\\/09\\\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Vacunacion-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Vacunacion-1.jpg\",\"width\":1127,\"height\":733,\"caption\":\"Foto: Agencia IP\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/11\\\/09\\\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Salud P\u00fablica aprueba uso de AstraZeneca en mayores de 18 a\u00f1os de edad\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"name\":\".::Agencia IP::.\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\",\"name\":\"Agencia IP\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"width\":150,\"height\":150,\"caption\":\"Agencia IP\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPParaguay\\\/\",\"https:\\\/\\\/x.com\\\/IPParaguay\",\"https:\\\/\\\/www.instagram.com\\\/IPParaguay\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/791af27a9219bdbf9064abb776bb41c2\",\"name\":\"Noelia Ferreira\",\"sameAs\":[\"http:\\\/\\\/www.ip.gov.py\"],\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/author\\\/nferreira\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Salud P\u00fablica aprueba uso de AstraZeneca en mayores de 18 a\u00f1os de edad - .::Agencia IP::.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/","og_locale":"es_ES","og_type":"article","og_title":"Salud P\u00fablica aprueba uso de AstraZeneca en mayores de 18 a\u00f1os de edad - .::Agencia IP::.","og_description":"Asunci\u00f3n, Agencia IP.- El Ministerio de Salud P\u00fablica aprob\u00f3 la vacunaci\u00f3n con AstraZeneca a personas mayores de 18 a\u00f1os en adelante, tras la recomendaci\u00f3n del Comit\u00e9 Nacional Asesor de Inmunizaciones (Cotenai), que expuso resultados de evidencias cient\u00edficas que demuestran la seguridad de esta vacunas en este grupo etario.","og_url":"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/","og_site_name":".::Agencia IP::.","article_publisher":"https:\/\/www.facebook.com\/IPParaguay\/","article_published_time":"2021-11-09T11:40:04+00:00","og_image":[{"width":1127,"height":733,"url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/11\/Vacunacion-1.jpg","type":"image\/jpeg"}],"author":"Noelia Ferreira","twitter_card":"summary_large_image","twitter_creator":"@IPParaguay","twitter_site":"@IPParaguay","twitter_misc":{"Escrito por":"Noelia Ferreira","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/#article","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/"},"author":{"name":"Noelia Ferreira","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/791af27a9219bdbf9064abb776bb41c2"},"headline":"Salud P\u00fablica aprueba uso de AstraZeneca en mayores de 18 a\u00f1os de edad","datePublished":"2021-11-09T11:40:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/"},"wordCount":374,"publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/11\/Vacunacion-1.jpg","keywords":["AstraZeneca","paraguay","Plan Nacional de Vacunaci\u00f3n anticovid-19","Salud P\u00fablica"],"articleSection":["Destacado","Nacionales"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/","url":"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/","name":"Salud P\u00fablica aprueba uso de AstraZeneca en mayores de 18 a\u00f1os de edad - .::Agencia IP::.","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/#primaryimage"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/11\/Vacunacion-1.jpg","datePublished":"2021-11-09T11:40:04+00:00","breadcrumb":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/#primaryimage","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/11\/Vacunacion-1.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/11\/Vacunacion-1.jpg","width":1127,"height":733,"caption":"Foto: Agencia IP"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/11\/09\/salud-publica-aprueba-uso-de-astrazeneca-en-mayores-de-18-anos-de-edad\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ip.gov.py\/ip\/"},{"@type":"ListItem","position":2,"name":"Salud P\u00fablica aprueba uso de AstraZeneca en mayores de 18 a\u00f1os de edad"}]},{"@type":"WebSite","@id":"https:\/\/www.ip.gov.py\/ip\/#website","url":"https:\/\/www.ip.gov.py\/ip\/","name":".::Agencia IP::.","description":"","publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ip.gov.py\/ip\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ip.gov.py\/ip\/#organization","name":"Agencia IP","url":"https:\/\/www.ip.gov.py\/ip\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","width":150,"height":150,"caption":"Agencia IP"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPParaguay\/","https:\/\/x.com\/IPParaguay","https:\/\/www.instagram.com\/IPParaguay"]},{"@type":"Person","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/791af27a9219bdbf9064abb776bb41c2","name":"Noelia Ferreira","sameAs":["http:\/\/www.ip.gov.py"],"url":"https:\/\/www.ip.gov.py\/ip\/author\/nferreira\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/391579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/comments?post=391579"}],"version-history":[{"count":0,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/391579\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media\/391584"}],"wp:attachment":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media?parent=391579"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/categories?post=391579"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/tags?post=391579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}